Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Depreciation & Amortization (CF) (2024 - 2025)

Profound Medical (PROF) has 2 years of Depreciation & Amortization (CF) data on record, last reported at $62000.0 in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 61.25% year-over-year to $62000.0; the TTM value through Dec 2025 reached $373000.0, down 47.24%, while the annual FY2025 figure was $373000.0, 47.24% down from the prior year.
  • Depreciation & Amortization (CF) reached $62000.0 in Q4 2025 per PROF's latest filing, down from $93000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $199000.0 in Q1 2024 and bottomed at $62000.0 in Q4 2025.